Cargando…
Cyclophosphamide for the treatment of acute lymphoblastic leukemia: A protocol for systematic review
BACKGROUND: Previous clinical trials have reported that cyclophosphamide can be used for the treatment of acute lymphoblastic leukemia (ALL). However, its efficacy is still unclear. In this systematic review study, we aim to evaluate its efficacy and safety for ALL. METHODS: The following 9 database...
Autores principales: | Zhao, Yue-rong, Song, Hong-mei, Ni, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380740/ https://www.ncbi.nlm.nih.gov/pubmed/30702599 http://dx.doi.org/10.1097/MD.0000000000014293 |
Ejemplares similares
-
Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia
por: Liu, Yu, et al.
Publicado: (2022) -
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
por: Zhang, Haiyan, et al.
Publicado: (2023) -
Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
por: Guzauskas, Gregory F., et al.
Publicado: (2017) -
Improving the Treatment of Acute Lymphoblastic Leukemia
por: Radadiya, Ashish, et al.
Publicado: (2020) -
Compliance with a protocol for acute lymphoblastic leukemia in childhood
por: de Oliveira, Benigna Maria, et al.
Publicado: (2011)